Danita Lucette Peoples-peterson, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5103 Eastman Ave, Suite 255, Midland, MI 48640 Phone: 989-832-7915 Fax: 989-832-7915 |
Dr. Jennifer Nash, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 728 W Wackerly St, Midland, MI 48640 Phone: 989-837-6868 |
Dr. Stephen Glover Lang, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 555 West Wackerly Street, Suite 3500, Midland, MI 48640 Phone: 989-839-1234 Fax: 989-839-7090 |
News Archive
BVM Capital today announced that it has made a seed round investment in health and fitness gaming innovator Fitness Interactive Experience (FIX). FIX is dedicated to helping people achieve enhanced levels of fitness and health by making fitness fun, accessible and socially connected through harnessing the power of massively multiplayer on-line games. FIX is developing an interactive social media platform designed to make the pursuit of fitness an engaging and enjoyable game.
Current estimates predict the number of obese school children in Europe will reach 6.4 million by the year 2010 if present trends continue.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Nifedipine Extended-release Tablets USP, 30 mg, 60 mg and 90 mg, the generic version of Pfizer's Procardia XL® Tablets, a treatment for angina and/or hypertension.
Public opinion surveys could be used more widely to understand regional variation in vaccine hesitancy, experts have recommended.
Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.
› Verified 8 days ago